This is the convertible debt I have been speaking to. As of Q3 they had 1.6M note payable which converts to shares at .003 vs current price. The appreciated value is all equity they are pulling out and hopefully using to pay down expansion and research. They are close to 100M in total shares converted since beginning of 2018 which is about 25-30M dollars of equity they have pulled...they have committed by YE to have all the going concerns resolved...this includes the litigation and the note payable. As of right now they could potential convert and double the total share count to the total authorized share amount of 1B shares...they did a good job offsetting the effect during the summer when they converted 216M shares to preferred...those shares were mostly if not all for Kevin Hagen who is the President of first venture (Diamond CBD).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.